Could a tiny pill fight cancer treatment exhaustion?
NCT ID NCT07224009
Summary
This study aims to see if a small daily dose of a medication called naltrexone (LDN) can safely help reduce severe tiredness (fatigue) in men with prostate cancer who are receiving hormone therapy. It will involve 60 men who report significant fatigue. Researchers will measure changes in energy levels, quality of life, and check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.